This trend of hypomethylation in advanced NAFLD, similar to observations in T2D (64, 65), may be of interest for the design of novel interventions to improve insulin sensitivity (addressed in more detail in the section “Epigenetic modifications can be long-term: Dietary methyl donors”). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.